ArticleThe Journal of antimicrobial chemotherapy2019

Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy.

Jason Gillman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.